Sigma-Aldrich, Atlas Antibodies Release 2,200 Prestige Antibodies; Target 22K by 2015

The antibodies, which Sigma-Aldrich said are the industry's most highly validated, are developed by the administrators of the Human Protein Atlas and are aimed at addressing a dearth of high-quality commercially available antibodies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.